Hiv Infection

Hiv Infection - most related articles:

- PRO 2000 anti HIV gel is ineffective - 2.5
- Gastric acid protects against foodborne diseases - 2.4
- New treatment for severe 2009 H1N1 infection - 2.4
- Avian influenza situation in Egypt - a new case detected - 2.3
- HIV and AIDS cases increasing among young black gay men in US - 2.3
- Clostridium infection increasing hospitalized children - 2.1
- Human Swine Influenza Investigation in US - 2.1
- Incivek for hepatitis C infection is approved in US - 2.1
- Obesity raises urinary tract infection risk - 2
- HIV risk high in indian women abused by husbands - 2

Hiv Infection articles

New drug targets aimed at slowing progression of HIV AIDS
Researchers reveal a mechanism by which the immune system tries to halt the spread of HIV. Harnessing this mechanism may open up new paths for therapeutic research aimed at slowing the virus' progression to AIDS.

HIV infections and AIDS related cases reduced
New HIV infections and AIDS-related deaths have fallen to the lowest levels since the peak of the epidemic. New HIV infections were reduced by 21% since 1997, and deaths from AIDS-related illnesses decreased by 21% since 2005.

Hormonal contraception doubles HIV risk in Africa
Women using hormonal contraception -- such as a birth control pill or a shot like Depo-Provera – are at double the risk of acquiring HIV, and HIV-infected women who use hormonal contraception have twice the risk of transmitting the virus to their HIV-uninfected male partners.

Odds for detecting HIV varies by method
The odds for effectively detecting HIV in African-American men vary by method, researchers have found in a recent study, which appears in the Annals of Behavioral Medicine.

HIV and AIDS cases increasing among young black gay men in US
While blacks represent 14 percent of the U.S. population, they accounted for 44 percent of new HIV infections in 2009. HIV infection rates among blacks were nearly eight times higher than rates in whites.

HIV infection may be a risk factor for heart failure
Patients with HIV infection without a prior history of coronary heart disease may be at a higher risk of developing heart failure, according to a report in the Archives of Internal Medicine.

HIV rates declined in Zimbabwe driven by fear of infection
The big drop in the numbers of people infected with HIV in Zimbabwe is because of mass social change, driven by fear of infection, according to an international study reported in the journal PLoS Medicine.

HIV screening cost effective in reducing spread of AIDS
An expanded U.S. program of HIV screening and treatment could prevent as many as 212,000 new infections over the next 20 years and prove to be very cost-effective, according to a new study by Stanford University School of Medicine researchers.

New research to drive novel ways of treating and preventing HIV
The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference (AIDS 2010) taking place in Vienna, Austria said today.

Antibodies can stop most HIV strains from infecting human cells
Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat.

Chemical in banana a potent inhibitor of HIV infection
A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week.

Clinic based HIV prevention is effective in reducing risk behaviors
Delivering HIV prevention services to people living with HIV in clinical settings can sharply reduce their sexual risk behaviors, revealed by UCSF researchers.

Bone marrow can harbor HIV infected cells
University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. This indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.

Routine HIV screening in community boosts HIV testing
UCSF researchers have that found routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV.

PRO 2000 anti HIV gel is ineffective
Pro 2000, a vaginal microbicide gel designed to reduce women's risk of HIV infection, showed no evidence that it reduces the risk of HIV infection, revealed by researchers at Britain's Medical Research Council (MRC).

New HIV vaccine safe and effective in preventing HIV infection
In an encouraging development, an investigational vaccine regimen has been shown to be well-tolerated and to have a modest effect in preventing HIV infection in a clinical trial involving more than 16,000 adult participants in Thailand.

High HIV infection rate among Soweto Township gays
New research from UCSF examining HIV among men (MSM) in the township of Soweto in South Africa has found that a third of gay-identified men are infected with HIV.

GSK to fight HIV AIDS in Africa
GlaxoSmithKline's CEO Andrew Witty announced a series of new initiatives targeted at improving research, development, and access to HIV/AIDS medicines for children in Sub-Saharan Africa and supporting healthcare for people living with HIV and AIDS.

HIV progresses faster in women than in men
One of the continuing mysteries of the HIV/AIDS epidemic is why women usually develop lower viral levels than men following acute HIV-1 infection but progress faster to AIDS than men with similar viral loads.

AIDS virus damages gut antibody-producing immune cells
A new research from the NIAID-funded Center for HIV/AIDS Vaccine Immunology suggests that HIV-1 is anything but – moving at breathtaking speed in destroying and dysregulating the body's gut-based B-cell antibody-producing system.

South Africa's HIV epidemic has stabilised
South Africa's HIV epidemic has levelled off at a prevalence of 10.9% for people aged two years and older, with 5.2 million people estimated to be living with HIV in 2008.

Low cost HIV monitoring test gives result in 30 min
Scientists at the Burnet Institute, Australia's leading medical research and public health institute focused on infectious diseases, have developed a prototype low-cost HIV monitoring test designed for field use in remote settings.

HIV vaccine by using gene transfer technology
A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.

GSK and Pfizer to create a new HIV company
GlaxoSmithKline plc (GSK) and Pfizer Inc (PFE) announced they have entered into an agreement to create a new world-leading HIV company focused solely on research, development and commercialisation of HIV medicines.

Education slowing HIV AIDS in sub-Saharan Africa
Increased schooling across sub-Saharan Africa may be lowering new HIV infections among younger adults, according to sociologists, suggesting a shift in a decades-long trend where formal education is considered an AIDS risk factor.

HIV/AIDS statistics for women and girls startling in US
In US the percentage of new AIDS cases diagnosed among women more than doubled between 1990 and 2005 (the most recent year for which data is available), increasing from 11 percent to more than 26 percent.

Microbicide promising as HIV prevention method for women
A clinical trial involving more than 3,000 women in the U.S. and southern Africa demonstrates for the first time the promise of a vaginal microbicide gel for preventing HIV infection in women.

New monkey model for HIV
By altering just one gene in HIV-1, scientists have succeeded in infecting pig-tailed macaque monkeys with a human version of the virus that has until now been impossible to study directly in animals.

Evolutionary biologist gets grant to study HIV
Dr. Sara Sawyer will use a $120,000 grant from the Foundation for AIDS Research (amFAR) to study how the HIV virus and the cells it attacks have evolved together over time. The goal of her research is to discover new targets for drugs.

Anti HIV gel shows promise in preventing HIV infection in women
An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States.

National Black HIV AIDS Awareness and Information Day
The scourge of HIV/AIDS, which continues to affect the African-American community disproportionately, highlights the importance of a comprehensive strategy to address the U.S. epidemic.

Pk antigen in blood raises resistance to HIV
Researchers have discovered a potentially important new resistance factor in the battle against HIV: blood types. An international team of researchers from Canadian Blood Services, The Hospital for Sick Children (SickKids) and Lund University in Sweden have discovered that certain blood types are more predisposed to contracting HIV, while others are more effective at fending it off.

Circumcision reduces HIV risk in US men
A new U.S. study has found that being circumcised significantly reduced the risk of HIV infection in heterosexual African American men known to have been exposed to the virus.

109 medicines, vaccines in development for HIV AIDS
America's pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

Routine HIV testing fails in US
While the U.S. AIDS epidemic simmers largely unnoticed by most Americans, a failure to widely implement routine HIV testing continues to fuel its spread, HIV researchers and experts said.

TIM 3 protein turns off HIV fighting T cells
In HIV-infected patients the body's immune system is unable to fight off the virus. A new study to be published online on November 10th in the Journal of Experimental Medicine shows that T cells in HIV-infected individuals express a protein called TIM-3, which inactivates their virus killing capacity.

HIV began spreading among humans between 1884 and 1924
New research indicates that the most pervasive global strain of HIV began spreading among humans between 1884 and 1924, suggesting that growing urbanization in colonial Africa set the stage for the HIV/AIDS pandemic.

India to develop HIV AIDS vaccine soon
A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced.

HIV risk high in indian women abused by husbands
Married women in India who experience physical and sexual violence from their husbands have an increased risk of HIV infection, compared with women who are not abused by their husbands, according to a study in the August 13 issue of JAMA, a theme issue on violence and human rights.

International AIDS Society updates treatment guidelines for HIV infection
An evaluation of recent data has led to an update in the guidelines and recommendations for antiretroviral treatment of adult human immunodeficiency virus (HIV) infection, according to an article in the August 6 issue of JAMA, a theme issue on HIV/AIDS.

40% higher HIV infection estimate in US
The Centers for Disease Control and Prevention (CDC) is expected soon to increase the estimate of new HIV infections in the United States by 40 percent. This highlights the need to make HIV testing a routine part of medical care and provide better funding to care for those who test positive, according to the HIV Medicine Association (HIVMA).

Genetic variation in Africans raises HIV risk
A genetic variation which evolved to protect people of African descent against malaria has now been shown to increase their susceptibility to HIV infection by up to 40 per cent, according to new research. Conversely, the same variation also appears to prolong survival of those infected with HIV by approximately two years.

Oestrogen makes male organ resistant to HIV
Topical oestrogen applied to the human penis could stop the spread of HIV, revealed by Australian researchers at the University of Melbourne.

OPAL Therapy cost-effective method of treating HIV
Australian researchers have unveiled a new immunotherapy technique to help prevent the progression from HIV infection to AIDS. Details of the simple, cost-effective technique are published May 2nd in the open-access journal PLoS Pathogens.

CD16 monocyte could be a biomarker for progression of HIV
An increase in the CD163+/CD16+ monocyte subset could be a biomarker for the progression of HIV disease, according to researchers at Temple University, reported in the March issue of AIDS Research and Human Retroviruses.

HIV cases reduced in New Zealand
The New Zealand AIDS Foundation is welcoming the reduction in overall numbers of new HIV diagnoses in 2007, in particular that diagnoses among gay and bisexual men have remained equivalent to 2006 levels.

HIV AIDS organisations to highlight progress and lessons learned
HIV/AIDS implementers from around the world will gather in Kampala, Uganda, from June 3-7 for the 2008 HIV/AIDS Implementers' Meeting. Recognizing the rapid expansion of HIV/AIDS programs worldwide, the focus of this year's meeting is building the capacity of local prevention, treatment, and care programs; enhancing quality; and promoting coordination among partners.

Researchers discover TRIM22 gene that blocks HIV
Researchers at the University of Alberta have discovered a gene that is able to block HIV, and in turn prevent the onset of AIDS. Stephen Barr, a molecular virologist in the Department of Medical Microbiology and Immunology, says his team has identified a gene called TRIM22 that can block HIV infection in a cell culture by preventing the assembly of the virus.

Anti HIV gel Tenofovir proven safe for women
An experimental anti HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.

Copper inhibits transmission of hiv through breast milk and blood
Researchers from the U.S. and abroad have developed an inexpensive copper-based filter that may prevent HIV from being passed through breast milk and blood. They report their findings in the February 2008 issue of the journal Antimicrobial Agents and Chemotherapy.

Many maternal deaths worldwide are preventable
Women who die during pregnancy and childbirth in sub-Saharan Africa, more may die from treatable infectious diseases than from conditions directly linked to pregnancy, revealed by researchers.

Scientists identify new cellular receptor for HIV
A cellular protein that helps guide immune cells to the gut has been newly identified as a target of HIV when the virus begins its assault on the body's immune system, according to researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

HIV can be transmitted through pre-chewed food
HIV can be transmitted to infants through food that is pre-chewed by an HIV-positive parent or caregiver, CDC researchers said Wednesday at the 15th Conference on Retroviruses and Opportunistic Infections in Boston, the New York Times reports. Specific findings from the study have not been released, the Times reports.

Intelence, etravirine HIV Drug approved in US
US FDA approved Tibotec Therapeutics' Intelence, etravirine tablets for the treatment of HIV infection, to be used in combination with other anti-HIV medications, in adults who have failed treatment with other antiretrovirals.

HIV is infecting men, women and children of all ages
Not everyone, who becomes infected with HIV, originates from a 'High Risk' group. The common usage of the words 'high risk', in reference to people, who are most likely to become infected with HIV, has led many to believe misguidedly that they are not at risk. Unfortunately, this belief couldn't be further from the truth.

AIDS drugs may prevent vaginal transmission of HIV
Prescription drugs now used to treat human immunodeficiency virus infection in adults may prevent the vaginal transmission of HIV, researchers at UT Southwestern Medical Center have found.

New warning for nonoxynol 9 OTC contraceptives in US
The U.S. Food and Drug Administration (FDA) issued a final rule that requires that manufacturers of over-the-counter (OTC) stand-alone vaginal contraceptive and spermicidal products containing the chemical ingredient nonoxynol 9 (N9) include a warning that the chemical N9 does not provide protection against infection from HIV (the virus that causes AIDS) or other sexually transmitted diseases (STDs).

Treatment of HIV associated Lipodystrophy Syndrome
Researchers in Montreal and Boston have identified a potential new treatment for the HIV/HAART*-associated Lipodystrophy Syndrome. This syndrome is a common side-effect of anti-retroviral medications to treat HIV infection.

Stars in Sierre Leone AIDS awareness campaign
Manchester United stars Ryan Giggs, Rio Ferdinand and Patrice Evra have joined forces with UNICEF to front a new AIDS awareness advertising campaign in Sierra Leone.

Mobile phone users to to find an HIV testing center near them
In the United States, an estimated 1 million people are living with HIV; of these, approximately 25 percent are unaware of their HIV infection and at increased risk for infecting others. The earlier people know they have HIV, the sooner they can benefit from life-extending treatment, and reduce the risk of infecting their partners.

60 Hiv Infection articles listed above.


Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
11.99